Sign in
4

Changes in Ownership

Royalty Pharma plc Filed Acc 0001802768-25-000105

CEO, Chairman of the Board acquired 21,901 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Legorreta Pablo G. CEO, Chairman of the Board 2025-08-06 Grant or award +21,901 904,396 D
Derivatives
Legorreta Pablo G. CEO, Chairman of the Board 2025-08-08 Gift · LP interests in RPI US Partners 2019, LP −60,000 692,701 D
Loading xslF345X05/wk-form4_1754686796.xml…